Reduction of serum parathyroid hormone levels during sympathetic stimulation in man
- PMID: 3584853
- DOI: 10.1007/BF03347181
Reduction of serum parathyroid hormone levels during sympathetic stimulation in man
Abstract
The parathyroid glands contain sympathetic nerve endings and the parathyroid cells are endowed with beta-adrenergic receptors. The physiological role of the sympathoadrenal system for the secretion of parathyroid hormone (PTH) has, however, not been clarified. Using the technique of lower body negative pressure (LBNP), which is an established method to achieve sympathetic nerve activation, it was found in 17 healthy subjects that the venous serum levels of PTH were reduced by 7% within 20 min [from 0.79 +/- 0.12 (SD) to 0.74 +/- 0.11 arbU/l, p less than 0.01, paired t test]. The reduction corresponds to 30% of the maximal suppressibility of PTH by induced hypercalcemia or following parathyroidectomy when studied with the same PTH assay and with the short time period involved. After cessation of LBNP the PTH levels returned to baseline within 20 min. There were no concomitant changes of the plasma ionized calcium concentrations. The findings are compatible with a role for the sympathetic nervous system in the physiologic regulation of the secretion of PTH.
Similar articles
-
Ionized calcium and the in vivo response of normal and hyperplastic parathyroid glands to beta-adrenergic agents.Nephron. 1982;32(2):149-54. doi: 10.1159/000182835. Nephron. 1982. PMID: 7177292 Clinical Trial.
-
Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.J Clin Endocrinol Metab. 1989 Apr;68(4):831-6. doi: 10.1210/jcem-68-4-831. J Clin Endocrinol Metab. 1989. PMID: 2921312
-
Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion.Acta Physiol Scand. 2005 Jun;184(2):113-9. doi: 10.1111/j.1365-201X.2005.01436.x. Acta Physiol Scand. 2005. PMID: 15916671
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
In vivo studies of parathyroid gland function in secondary hyperparathyroidism.Adv Nephrol Necker Hosp. 1996;25:289-302. Adv Nephrol Necker Hosp. 1996. PMID: 8717632 Review.
Cited by
-
Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.Neuromolecular Med. 2018 Mar;20(1):37-53. doi: 10.1007/s12017-018-8481-2. Epub 2018 Feb 10. Neuromolecular Med. 2018. PMID: 29429076 Review.
-
Acute effects of the resistance exercise associated with different blood flow restriction pressures on bone remodeling biomarkers.J Exerc Sci Fit. 2022 Apr;20(2):155-160. doi: 10.1016/j.jesf.2022.02.005. Epub 2022 Mar 8. J Exerc Sci Fit. 2022. PMID: 35356103 Free PMC article.
-
Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet.Br J Clin Pharmacol. 2019 Jun;85(6):1312-1325. doi: 10.1111/bcp.13900. Epub 2019 Apr 25. Br J Clin Pharmacol. 2019. PMID: 30756425 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources